Skip to main content
. Author manuscript; available in PMC: 2016 Jul 16.
Published in final edited form as: Int J Neuropsychopharmacol. 2010 Sep 22;14(4):445–457. doi: 10.1017/S1461145710001136

Table 1.

Demographic information for the patient and control groups

Subject FMPP
(n = 13)
Mean (s.d.)
Control
(n = 39)
Mean (s.d.)
Age (yr) 12.7 (3.2) 14.3 (2.5)
Bone age (yr)a 14.7 (3.2)
Age range (yr) 9–19 9–19
Age of diagnosis
Sex Male Male
Intelligence Quotient 109 (14.0) 116 (10.4)
Aggression rating (LHA) 8.4 (5.3)
Anxiety rating (SCARED) 13.3 (6.8)
Tanner stageb 3.9 (1.1) 3.4 (1.0)
Testosterone total (ng/dl) 379 (168)
Testosterone free (ng/dl) 43 (41)
Height (cm) 157.9 (19.0)
Weight (kg) 57.6 (28.3)
Body mass index 21.8 (5.7)

FMPP, Familial male precocious puberty; LHA, Lifetime History of Aggression scale; SCARED, Screen for Child Anxiety Related Emotional Disorders.

a

Note that chronological age equals bone age in healthy youth.

b

Information for Tanner stage of nine control subjects is missing.